IP Library Granted Patent US 10,137,111
Granted Patent B2
US 10,137,111 · App. 15/675,435 · Granted Nov 27, 2018

Drug compositions comprising an anti-parasitic and proton pump inhibitor

Inventors: David Clayton Sutherland (Little Rock, AR); James Kyle Zorn (Lexington, KY); Dennis J. Carlo (San Diego, CA)
Assignee: Adamis Pharmaceuticals Corporation
A61K31/4184A61K9/1641A61K9/1652A61K31/4439A61K45/06A61K47/38A61K2300/00C01D5/14C01D7/10C08B3/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,137,111
App. No.
15/675,435
Granted
Nov 27, 2018
Kind
B2
Abstract

Described herein are pharmaceutical compositions including a proton pump inhibitor and an antiparasitic drug. In some embodiments, the compositions can be formulated as a non-solid for oral administration. The compositions can be used to treat gastrointestinal conditions. Methods of treatment using the compositions are also described.

Claims (12)

1. A composition including:

a paste including about 22% w/v omeprazole, about 30% w/v fenbendazole, and a wetting agent formulated in a melted polyethylene glycol base agent for oral administration to a mammal.

2. The composition of claim 1 , wherein the wetting agent is a polyethylene glycol.

3. The composition of claim 1 , further including sodium sulfite.

4. The composition of claim 1 , further including carboxymethyl cellulose.

5. The composition of claim 1 , further including sodium bicarbonate.

6. The composition of claim 1 , further including a flavoring agent.

7. The composition of claim 1 , wherein the mammal is a horse.

8. The composition of claim 1 , wherein the mammal is a camel.

9. An equine composition including a paste including a melted polyethylene glycol base agent including 22% omeprazole, 30% fenbendazole, a wetting agent, and carboxymethyl cellulose formulated for administration from an oral syringe.

10. A composition including:

a paste including about 22% w/v omeprazole, about 30% w/v fenbendazole, carboxymethylcellulose, a preservative, and a wetting agent formulated in a melted polyethyleneglycol base agent for oral administration to a mammal.

Assignments (5)
SECURITY INTEREST Recorded May 13, 2026
From: FARMAKEIO OUTSOURCING LLC; FARMAKEIO AR LLC
To: FIRST-CITIZENS BANK & TRUST COMPANY, AS ADMINISTRATIVE AGENT
Reel/Frame 074646/0453 →
NUNC PRO TUNC ASSIGNMENT Recorded Oct 11, 2023
From: ADAMIS PHARMACEUTICALS CORPORATION
To: FARMAKEIO AR LLC
Reel/Frame 065183/0622 →
CHANGE OF NAME Recorded Sep 28, 2023
From: ADAMIS PHARMACEUTICALS CORPORATION
To: DMK PHARMACEUTICALS CORPORATION
Reel/Frame 065082/0445 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 11, 2017
From: CARLO, DENNIS J.
To: ADAMIS PHARMACEUTICALS CORPORATION
Reel/Frame 043273/0373 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 11, 2017
From: SUTHERLAND, DAVID CLAYTON; ZORN, JAMES KYLE
To: ADAMIS PHARMACEUTICALS CORPORATION
Reel/Frame 043273/0396 →
Continuity (2)
Provisional Application 62373871 · Aug 11, 2016
Related Publication 20180042901A1 · Feb 15, 2018